欧康维视生物-B(01477)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

01477 欧康维视生物-B

交易中 09-21 15:21:54

5.200

+0.105

+2.06%

最高5.400	最低5.175	成交量58.35万
今开5.250	昨收5.095	日振幅4.42%
总市值42.38亿	流通市值42.38亿	总股本8.15亿
成交额305.43万	换手率0.07%	流通股本8.15亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"01477","market":"HK","secType":"STK","nameCN":"欧康维视生物-B","latestPrice":5.2,"timestamp":1789975271444,"preClose":5.095,"halted":0,"volume":583500,"delay":0,"changeRate":0.020608439646712547,"floatShares":815000000,"shares":815000000,"eps":-0.2343613440763202,"marketStatus":"交易中","change":0.105,"latestTime":"09-21 15:21:54","open":5.25,"high":5.4,"low":5.175,"amount":3054275,"amplitude":0.044161,"askPrice":5.2,"askSize":12000,"bidPrice":5.19,"bidSize":6500,"shortable":3,"etf":0,"ttmEps":-0.18055783850999899,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1789978200000},"marketStatusCode":2,"adr":0,"listingDate":1594310400000,"exchange":"SEHK","adjPreClose":5.095,"openAndCloseTimeList":[[1789954200000,1789963200000],[1789966800000,1789977600000]],"volumeRatio":2.248383,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01477","defaultTab":"news","newsList":[{"id":"2669134948","title":"A股早盘高位震荡 深成指半日涨0.57% AI制药、新消费板块走强","url":"https://stock-news.laohu8.com/highlight/detail?id=2669134948","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669134948?lang=zh_cn&edition=full","pubTime":"2026-09-21 11:34","pubTimestamp":1789961645,"startTime":"0","endTime":"0","summary":"金吾财讯 | A股早盘高位震荡，截至午间收盘，沪指涨0.55%，深成指涨0.57%，创业板指涨0.93%。板块方面，AI制药、新消费、稀土、宠物经济等板块涨幅居前；贵金属、核力发电、保险、光刻机等板块跌幅居前。配置上沿压制缓解的科技、创新药、有配置差的化工链布局，红利仍作底仓配置用以降低波动。","market":"nz","thumbnail":"https://static.szfiu.com/news/20250109/YjFmNjZjNDg2MTA4NTI1ODgwMzI4.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/YjFmNjZjNDg2MTA4NTI1ODgwMzI4.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"299f0a9977df499f8ead781071e5e5e7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1992068","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1147","07233","399001","ARTY","03188","02827","BK4585","02846","XLPD","BK1191","83130","01477","XLP","82846","CHAT","BK1574","83188","BK4588","AGIX","AIPO","VTHR","QTOC","159982","03130","399300","XLPU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669539134","title":"楚天科技：持续向市场传递生物工程、智能制药装备等核心业务的经营进展与长期价值","url":"https://stock-news.laohu8.com/highlight/detail?id=2669539134","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669539134?lang=zh_cn&edition=full","pubTime":"2026-09-21 11:33","pubTimestamp":1789961586,"startTime":"0","endTime":"0","summary":"针对您提到的主动管理型医药主题基金，公司已通过业绩说明会、投资者调研接待、路演交流、投资者热线及互动易平台等多种渠道，持续向市场传递生物工程、智能制药装备等核心业务的经营进展与长期价值。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092100009752.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1574","300358","BK0061","BK1191","BK0077","BK0028","01477","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669813957","title":"港股异动 | 剂泰科技-P(07666)再涨超9% 多重共振带动AI制药上行 公司AI+递送平台价值逐步显现","url":"https://stock-news.laohu8.com/highlight/detail?id=2669813957","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669813957?lang=zh_cn&edition=full","pubTime":"2026-09-21 10:06","pubTimestamp":1789956363,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，剂泰科技-P再涨超9%，近三个交易日累涨超35%。这份纲领性文件将AI制药列入医药工业五年计划的重点任务，明确提出“深化人工智能赋能升级”，并专门列出“AI制药高价值应用场景培育”专栏。当前，AI制药正处于行业外新增资本与产业内研发预算双轮驱动的上行通道。行业内，礼来等MNC持续扩大AI在药物发现、临床前及研发流程中的应用；Anthropic则设立生物实验室，推进AI药物研发项目。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1498528.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["ARTY","AGIX","01477","BK1161","CHAT","07666","VTHR","VXUS","BK1191","BK4588","BK1574","AIPO","QTOC","KCAI","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669139317","title":"港股异动 | 金斯瑞生物科技(01548)早盘涨超7% 大模型厂商下场AI制药 机构指公司商业模型发生深刻变化","url":"https://stock-news.laohu8.com/highlight/detail?id=2669139317","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669139317?lang=zh_cn&edition=full","pubTime":"2026-09-21 10:04","pubTimestamp":1789956243,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，金斯瑞生物科技早盘涨超7%。截至发稿，涨6.56%，报41.92港元，成交额8.01亿港元。消息面上，金斯瑞近日宣布，与礼来的AIDD协作平台Lilly TuneLab达成合作。公司将向TuneLab参与企业提供湿实验服务，助力其快速生成实验数据，将AI预测转化为生物学验证数据，加速候选药物评估。光大证券指出，随着大模型厂商下场AI制药，公司的商业模型已发生深刻变化。基于客户需求，公司预计AI驱动蛋白订单预期26年下半年及之后保持3位数百分比增长。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1498525.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","ARTY","HK0000306685.HKD","QTOC","01477","EPAI","BK1574","AGIX","BK1583","LRNZ","01548","CHAT","WISE","HK0000320223.HKD","BK4585","AIPO","HK0000306701.USD","HK0000320264.USD","KCAI","GPTZ","BK1191","BK1141","VXUS","VTHR","BK1576"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669136084","title":"化学制药板块短线拉升","url":"https://stock-news.laohu8.com/highlight/detail?id=2669136084","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669136084?lang=zh_cn&edition=full","pubTime":"2026-09-21 09:40","pubTimestamp":1789954830,"startTime":"0","endTime":"0","summary":"化学制药板块短线拉升","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609213879641222.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609213879641222.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1191","01477","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669335451","title":"澳大利亚Telix制药公司16.5亿美元收购德国 ITM","url":"https://stock-news.laohu8.com/highlight/detail?id=2669335451","media":"环球市场播报","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669335451?lang=zh_cn&edition=full","pubTime":"2026-09-21 08:02","pubTimestamp":1789948920,"startTime":"0","endTime":"0","summary":"澳大利亚Telix制药公司周一宣布，已同意以约 16.5 亿美元的价格（基于无现金、无债务的估值）收购总部位于德国的 ITM Isotope Technologies Munich SE。经调整后，预计 ITM 股东将获得价值约12.5亿美元的Telix股份，作价为每股 11.84 美元。Telix制药公司表示，ITM具备商业规模且盈利能力强的同位素生产业务，不仅能显著贡献现金流，还将进一步巩固Telix治疗药物管线所需的同位素供应链。交易完成后，Telix现有股东将持有Telix约76.3%的股份，而ITM股东将持有约23.7%的股份。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-09-21/doc-inispuef2165475.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["01477","FDXSmain","BK1191","BK1574","FDXMmain","FDAXmain"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669387721","title":"澳大利亚Telix制药（Telix Pharmaceuticals）于2026年9月21日宣布，已同意以总价值最高达23","url":"https://stock-news.laohu8.com/highlight/detail?id=2669387721","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669387721?lang=zh_cn&edition=full","pubTime":"2026-09-21 07:57","pubTimestamp":1789948640,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["TLX","BK1574","01477","BK1191","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668928752","title":"Anthropic悄悄建起生物实验室！Claude指挥机器人做实验，AI制药再进一步","url":"https://stock-news.laohu8.com/highlight/detail?id=2668928752","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668928752?lang=zh_cn&edition=full","pubTime":"2026-09-18 19:37","pubTimestamp":1789731450,"startTime":"0","endTime":"0","summary":"Anthropic在旧金山湾区悄然建立实体生物实验室，招聘生物化学人才，标志其生命科学战略从计算模拟迈向真实实验。公司通过收购、推出Claude Science及设备操控标准，推动AI直接指挥实验、加速临床前药物研发。此举发生在筹备IPO与AI生物安全争议的敏感期，数据隔离与安全风险备受关注。","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"6e7a4338b1034ad785d5025385d8625c","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3782086","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01477","AGIX","CHAT","BK1191","VTHR","PBOT","BK1574","ARTY","AIPO","KOMP","QTOC","ROBO"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2668294233","title":"一键布局AI制药，首选高含量ETF","url":"https://stock-news.laohu8.com/highlight/detail?id=2668294233","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668294233?lang=zh_cn&edition=full","pubTime":"2026-09-18 17:42","pubTimestamp":1789724520,"startTime":"0","endTime":"0","summary":"💊 一键布局AI制药，首选高含量ETF👇🏻🏥 港股通医疗ETF华宝#159137🧬 标的指数“AI制药含量”69.5%，全市场第一❗MACD金叉信号形成，这些股涨势不错！","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-09-18/doc-inisfyfa8394210.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["FDN","BK4550","QTOC","BK4588","AIPO","CHAT","AGIX","BK1191","BK4585","VTHR","ARTY","BK1574","01477"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668291034","title":"大行评级丨大和：中生制药管理层重申今年收入增长双位数指引，评级“买入”","url":"https://stock-news.laohu8.com/highlight/detail?id=2668291034","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668291034?lang=zh_cn&edition=full","pubTime":"2026-09-18 13:56","pubTimestamp":1789711016,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK1574","01477","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668891996","title":"AI制药概念股早盘集体走高 剂泰科技-P涨逾13%英硅智能涨逾11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2668891996","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668891996?lang=zh_cn&edition=full","pubTime":"2026-09-18 10:11","pubTimestamp":1789697460,"startTime":"0","endTime":"0","summary":"热点栏目自选股\n数据中心\n行情中心\n资金流向\n模拟交易客户端AI制药概念股早盘集体走高，截至发稿，剂泰科技-P（07666）上涨13.20%，报17.58港元；英硅智能（03696）上涨10.98%，报59.65港元；晶泰控股（02228）上涨8.34%，报7.47港元；金斯瑞生物科技（01548）上涨6.39%，报39.60港元。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-09-18/doc-inisfazi3502899.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["AIPO","ARTY","CHAT","BK1161","VTHR","01477","AGIX","BK1191","QTOC","BK1574","07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668196179","title":"“十五五”规划力挺AI制药！英硅智能大涨近13%创5月以来新高","url":"https://stock-news.laohu8.com/highlight/detail?id=2668196179","media":"格隆汇","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668196179?lang=zh_cn&edition=full","pubTime":"2026-09-18 10:05","pubTimestamp":1789697153,"startTime":"0","endTime":"0","summary":"9月18日，港股市场英硅智能拉升大涨近13%报60.6港元，股价创5月以来新高，截至目前成交额放大至超6亿港元。英硅智能是全球AI药物研发领域的龙头标的之一。《规划》对AI制药政策面的强力支持，为其技术应用提供了最直接的政策红利与产业落地空间。","market":"us","thumbnail":"http://imgcloud.jrjimg.cn/2026/09/cms_20260918100553093.jpg","type":0,"news_type":0,"thumbnails":["http://imgcloud.jrjimg.cn/2026/09/cms_20260918100553093.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2026/09/18100558478274.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["VTHR","AIPO","BK1574","01477","CHAT","QTOC","ARTY","AGIX","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668291615","title":"港股异动 | AI制药进入战略入局阶段 剂泰科技-P(07666.HK)涨超11%领涨板块 英硅智能(03696.HK)涨超6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2668291615","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668291615?lang=zh_cn&edition=full","pubTime":"2026-09-18 09:36","pubTimestamp":1789695405,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["07666","BK1191","BK1141","03696","BK1161","01477","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668915943","title":"十部门：加快人工智能、量子计算、超级计算、计算医学等新技术赋能药物研发 探索超限制造、太空制药、生物制造等药械生产新模式","url":"https://stock-news.laohu8.com/highlight/detail?id=2668915943","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668915943?lang=zh_cn&edition=full","pubTime":"2026-09-18 09:04","pubTimestamp":1789693482,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["AIFD","NBDS","XQTM","OGIG","NEWZ","01477","PSQ","WPAI","IBBJ","DQJN","PBOT","AIQU","CPNQ","CRTC","KOMP","CHPX","QTUP","TECY","QQQ","QQA","AIBU","NJUL","QUA","TARK","161631","LCLG","ARTY","QPUX","QQQM","CQTM","FWD","MVPS","NJAN","SQQQ","CWC","LOUP","QTUM","AQGX","VUSE","WQTM","AGIX","QID","TQQQ","TQQY","GK","MFIG","QSWN","CHAT","QTOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668990558","title":"诺奖得主莱维特对话英硅智能CEO任峰，坦言AI制药发展远超他预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2668990558","media":"上观新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668990558?lang=zh_cn&edition=full","pubTime":"2026-09-18 06:00","pubTimestamp":1789682408,"startTime":"0","endTime":"0","summary":"“迈克尔，半个世纪前，您完成了全球首次蛋白质动力学模拟，那时用计算机研究生物学就像科幻小说。如今，人工智能可以预测蛋白质结构、生成全新分子、设计药物并推动它进入临床试验。人工智能+生物医药的发展速度，是否超出了您的预期？”英硅智能联合首席执行官、首席科学官任峰向诺贝尔化学奖得主、斯坦福大学教授迈克尔·莱维特提出了这个问题。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609183877705468.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609183877705468.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["QTOC","VTHR","BK1574","CHAT","AGIX","01477","AIPO","ARTY","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668692149","title":"AI制药站上风口！ETF怎么投？","url":"https://stock-news.laohu8.com/highlight/detail?id=2668692149","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668692149?lang=zh_cn&edition=full","pubTime":"2026-09-17 19:06","pubTimestamp":1789643160,"startTime":"0","endTime":"0","summary":"9月16日，AI制药领域三笔重磅合作同日落地：1、字节跳动孵化的Anew Labs完成2.9亿美元首轮外部融资正式独立。AI制药产业化加速，投资工具关注 AI制药含量近70% 港股通医疗ETF华宝#159137 AI+CRO、AI医疗 医疗ETF华宝#512170 AI+Biotech 港股通创新药ETF华宝#520880 AI+Biotech 药ETF华宝#562050 投龙头 · 选华宝 市场有风险 投资须谨慎！","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-09-17/doc-iniscvfx3581124.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["AIPO","QTOC","FDN","BK1574","VTHR","BK1191","CHAT","BK4550","AGIX","ARTY","BK4585","BK4588","01477"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668968254","title":"汇宇制药(688553.SH)股东黄干益拟被动减持不超2.46%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2668968254","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668968254?lang=zh_cn&edition=full","pubTime":"2026-09-17 17:19","pubTimestamp":1789636777,"startTime":"0","endTime":"0","summary":"智通财经APP讯，汇宇制药(688553.SH)发布公告，公司于近日收到股东黄干益出具的《关于被动减持计划告知函》，股东黄干益计划在履行减持股份预先披露义务的十五个交易日后的90天内(即2026年10月19日——2027年1月16日)合计减持不超过1539.23万股，占公司总股本比例不超过2.46%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1497411.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01477","BK1574","BK1191","688553","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668518799","title":"诺和诺德、礼来、字节系落子AI制药，A股创新药、CRO板块嗨了","url":"https://stock-news.laohu8.com/highlight/detail?id=2668518799","media":"华尔街见闻","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668518799?lang=zh_cn&edition=full","pubTime":"2026-09-17 14:26","pubTimestamp":1789626360,"startTime":"0","endTime":"0","summary":"诺和诺德与Anthropic达成AI合作，金斯瑞携手礼来TuneLab平台提供湿实验验证，字节拆分的Anew Labs亦获2.9亿美元融资。多重重磅合作与融资密集落地，显现AI制药协作热潮，带动A股创新药、CRO板块大涨。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"6e7a4338b1034ad785d5025385d8625c","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3781972","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07233","BK1147","BK1161","03188","AGIX","02827","IBBQ","83130","159982","03130","CHAT","06978","159992","BK1574","399300","BGIA","QTOC","VTHR","ARTY","BK1191","02846","MEDX","01477","82846","LNGR","83188","AIPO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668796959","title":"BD高增叠加AI制药大消息！CRO概念大涨 机构看好行业“量价齐升”(附股)","url":"https://stock-news.laohu8.com/highlight/detail?id=2668796959","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668796959?lang=zh_cn&edition=full","pubTime":"2026-09-17 14:14","pubTimestamp":1789625668,"startTime":"0","endTime":"0","summary":"9月17日早盘，医药板块全线走强，CRO概念逆势领涨，金石亚药20cm封板，百花医药亦强势涨停，近岸蛋白、万邦医药涨超10%，义翘神州、康希诺、宣泰医药、奥浦迈等多股跟涨。　　消息面上，诺和诺德与Anthropic达成合作，将使用ClaudeScience平台助力新药研发；同时，我国创新药出海步伐提速，对外授权交易总额已突破1200亿美元。作为产业链上的“卖水人”，CRO赛道景气度持续上行，有机构指出，CXO行业正从短期修复转向成长定价。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260917/32372898.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["CHAT","ARTY","AGIX","QTOC","01477","AIPO","VTHR","BK1191","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668930747","title":"港股异动 | 英硅智能(03696)盘中涨超6% 公司首款AI药物展现抗衰潜力 机构看好AI制药商业化爆发","url":"https://stock-news.laohu8.com/highlight/detail?id=2668930747","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668930747?lang=zh_cn&edition=full","pubTime":"2026-09-17 10:30","pubTimestamp":1789612210,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，英硅智能盘中最高涨逾6%，截至发稿，涨4.87%，报52.75港元，成交额2.85亿港元。消息面上，此前，英硅智能开发的一款用于治疗肺部疾病的实验性药物Rentosertib，在逆转生物衰老标志物方面展现出积极前景。目前该药物已迈入临床III期。花旗认为，英硅智能仍为该行人工智能药物发现子板块首选。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1497233.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4585","BK4588","KCAI","VXUS","ARTY","BK1191","VTHR","AGIX","01477","CHAT","AIPO","BK1141","QTOC","03696","BK1574"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ocumension.com","stockEarnings":[{"period":"1week","weight":-0.0441},{"period":"1month","weight":-0.0221},{"period":"3month","weight":0.0419},{"period":"6month","weight":-0.2659},{"period":"1year","weight":-0.4269},{"period":"ytd","weight":-0.3115}],"compareEarnings":[{"period":"1week","weight":-0.0022},{"period":"1month","weight":-0.0292},{"period":"3month","weight":0.0345},{"period":"6month","weight":-0.0208},{"period":"1year","weight":-0.0676},{"period":"ytd","weight":-0.0343}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"欧康维视生物是一家主要从事眼科药物的研发和商业化的公司。该公司产品主要包括OT-401“优施莹”氟轻松玻璃体内植入剂、OT-702“博优景”阿柏西普眼内注射溶液、OT-402“维速达尔”注射用维替泊芬、OT-204“欧沁”玻璃酸钠滴眼液及OT-305“贝特舒”盐酸倍他洛尔滴眼液等。该公司产品主要用于治疗葡萄膜炎、眼底疾病、屈光矫正、干眼症（DED）、青光眼及角结膜炎等各种眼前及眼后段疾病。该公司主要在中国国内市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.166667,"avgChangeRate":-0.097698},{"month":2,"riseRate":0.5,"avgChangeRate":-0.037557},{"month":3,"riseRate":0.5,"avgChangeRate":0.044668},{"month":4,"riseRate":0.5,"avgChangeRate":0.015642},{"month":5,"riseRate":0.5,"avgChangeRate":0.087204},{"month":6,"riseRate":0.666667,"avgChangeRate":0.062947},{"month":7,"riseRate":0.5,"avgChangeRate":-0.003589},{"month":8,"riseRate":0.428571,"avgChangeRate":-0.052517},{"month":9,"riseRate":0.142857,"avgChangeRate":-0.072946},{"month":10,"riseRate":0.166667,"avgChangeRate":-0.121217},{"month":11,"riseRate":0.333333,"avgChangeRate":0.004503},{"month":12,"riseRate":0.5,"avgChangeRate":0.058088}],"exchange":"SEHK","name":"欧康维视生物-B","nameEN":"OCUMENSION-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.0","shortVersion":"4.50.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"欧康维视生物-B(01477)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供欧康维视生物-B(01477)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"欧康维视生物-B,01477,欧康维视生物-B股票,欧康维视生物-B股票老虎,欧康维视生物-B股票老虎国际,欧康维视生物-B行情,欧康维视生物-B股票行情,欧康维视生物-B股价,欧康维视生物-B股市,欧康维视生物-B股票价格,欧康维视生物-B股票交易,欧康维视生物-B股票购买,欧康维视生物-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"欧康维视生物-B(01477)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供欧康维视生物-B(01477)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}